A comprehensive literature review linking algae and antivirals determines compounds in algae may demonstrate an exceptional—and as yet untapped—potential to combat viral diseases at every point along the viral infection pathway.
A Q&A with Lauren Charles, veterinarian and PNNL data scientist, on zoonotic diseases and the role biosurveillance plays in mitigating the growing threat to global health.
Three recent doctoral graduates are beginning their research careers at Pacific Northwest National Laboratory after completing the WSU-PNNL Distinguished Graduate Research Program this spring.
High school students from across Washington State competed in the Pacific Northwest Regional Science Bowl, hosted online by PNNL, for a chance to advance to the national competition in May.
For the second straight year, PNNL researchers are featured in a special edition of the Journal of Information Warfare. This issue explores the topic of macro cyber resiliency.
PNNL highlights four researchers whose joint appointments are creating new and diverse opportunities for expanding knowledge and scientific impact across institutions.
Sentry-SECURE is a new communication and response platform developed by PNNL, VPI, and Microsoft Azure that rapidly and securely transfers radiological alarm data through the cloud.
PNNL computational biologists, structural biologists, and analytical chemists are using their expertise to safely accelerate the design step of the COVID-19 drug discovery process.
Researchers at PNNL have developed a bacteria testing system called OmniScreen that combines biological and synthetic chemistry with machine learning to hunt down pathogens before they strike.
An award-winning ion separation technology developed at PNNL has been licensed for biomedical applications. Continued research aims to make the devices suitable for molecular analysis in the field. Â